EDGAR Filing Documents for 0000905718-19-000017

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0000905718-19-000017

Filing Date

2019-01-04

Accepted

2019-01-04 16:00:22

Documents

Period of Report

2018-12-31

Document Format Files

Seq	Description	Document	Type	Size
1		ownership.html	4
1		ownership.xml	4	3438
	Complete submission text file	0000905718-19-000017.txt		4833

Mailing Address C/O MATINAS BIOPHARMA HOLDINGS, INC. 1545 ROUTE 206 SOUTH, SUITE 302 BEDMINSTER NJ 07921

Business Address

Type: 4 | Act: 34 | File No.: 001-38022 | Film No.: 19509894

Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921

Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860

Matinas BioPharma Holdings, Inc. (Issuer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations